# Contact TB-500 Medicine: Editorial and Correction Requests

> Contact TB-500 Medicine about the thymosin beta-4 and TB-500 research digest — editorial questions, citation corrections, and source suggestions. Not a clinic, not a vendor, no medical advice.

For editorial questions, citation corrections, and source suggestions on the TB-500 and thymosin beta-4 digest. We do not provide medical advice and we do not sell anything.

## Reach the editorial desk

Use the form below for editorial matters about this TB-500 research digest: a citation that needs correcting, a peer-reviewed study you think belongs in the register, or a question about how a finding is summarized. We read corrections carefully — accuracy is the whole point of a console like this, and the fragment-versus-full-length distinction is exactly the kind of error we want flagged if we ever get it wrong.

What this desk cannot do: provide medical advice, recommend doses, advise on obtaining any substance, or act as a prescriber, pharmacy, or vendor. We do not manufacture, sell, or distribute TB-500 or any other compound, and we have no products and no order channel. Questions about purchasing, dosing protocols, or personal use fall outside what an editorial publisher can responsibly answer, and we will not answer them.

## Before you write

Most factual questions are already answered and cited on the site. For the science, start with the [research](/research) page and the [angiogenesis](/angiogenesis-research) lens; for dose context, the [dosage](/dosage) page; for the regulatory picture, the [legal status](/legal-status) page; and for quick answers, the [FAQ](/faq). Every quantitative claim links to its source on the [references](/references) page.

If your question is medical or personal, the right destination is a licensed healthcare professional who can evaluate your situation — not an editorial website. This site is a reading of the published literature, offered as general information, and nothing on it is medical or legal advice or an offer to sell or supply any substance.

---

A luminous console reading of the thymosin beta-4 literature — the Ac-LKKTETQ fragment mapped apart from the full-length protein it is sold as, the empty human-trial node and the FDA 503A status left lit, and no clinic behind the readout nor anything here dispensed.